Cargando…
Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors
Chimeric antigen receptor T (CAR-T) cells technology has been successfully used in the treatment of B cell-derived hematological tumors and multiple myeloma. CAR-T cells are also being studied in a variety of solid tumors. Current clinical reports on CAR-T cells in the treatment of malignant tumors...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772271/ https://www.ncbi.nlm.nih.gov/pubmed/36569917 http://dx.doi.org/10.3389/fimmu.2022.1079181 |